TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MAZE

Maze Therapeutics, Inc.

Healthcare · Biotechnology · —

23.40$ -2.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Maze Therapeutics, Inc. (MAZE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 532 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MAZE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
72 216 192 241 333 304 422 397 420 532
34 179 154 202 300 271 391 350 380 420
29 175 150 197 294 265 317 189 199 203
29 175 150 197 294 265 384 342 352 411
0.7 1.5 20 2.8
61 478 93 44 41 41 43 42 78 79
16 22 18 21 19 20 22 23 21 23
4.5 4.6 4.6 4.6 4.7 4.7 4.8 4.8 4.8 4.9
2.0 2.2 1.0 1.9 2.4 3.7 2.9 1.8 4.0 2.2
20 49 52 39 39
10 -262 99 197 292 262 379 355 342 453
-396 -289 -314 -358 -391 -425 -455 -490 -514 -558
44 44 44 44 44 44 44 44 46 43 54 59

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?